ID27275A - Intermediet dan proses untuk pembuatan olanzapin - Google Patents

Intermediet dan proses untuk pembuatan olanzapin

Info

Publication number
ID27275A
ID27275A IDW990058D ID990058D ID27275A ID 27275 A ID27275 A ID 27275A ID W990058 D IDW990058 D ID W990058D ID 990058 D ID990058 D ID 990058D ID 27275 A ID27275 A ID 27275A
Authority
ID
Indonesia
Prior art keywords
intermediet
olanzapin
making
making olanzapin
Prior art date
Application number
IDW990058D
Other languages
English (en)
Indonesian (id)
Inventor
Charles Arthur Bunnell
Samuel Dean Larsen
John Richard Nichols
Susan Marie Reutzel
Gregory Alan Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27275(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID27275A publication Critical patent/ID27275A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDW990058D 1996-09-23 1997-09-18 Intermediet dan proses untuk pembuatan olanzapin ID27275A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (1)

Publication Number Publication Date
ID27275A true ID27275A (id) 2001-03-22

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990058D ID27275A (id) 1996-09-23 1997-09-18 Intermediet dan proses untuk pembuatan olanzapin

Country Status (36)

Country Link
US (1) US6020487A (fr)
EP (1) EP0831098B1 (fr)
JP (2) JP2001500877A (fr)
KR (1) KR100560015B1 (fr)
CN (1) CN1122036C (fr)
AR (1) AR013838A1 (fr)
AT (1) ATE209208T1 (fr)
AU (1) AU719441B2 (fr)
BR (1) BR9712100A (fr)
CA (1) CA2265712C (fr)
CO (1) CO4910140A1 (fr)
CZ (1) CZ299248B6 (fr)
DE (1) DE69708428T2 (fr)
DK (1) DK0831098T3 (fr)
EA (1) EA001642B1 (fr)
EG (1) EG23861A (fr)
ES (1) ES2166051T3 (fr)
HK (1) HK1009807A1 (fr)
HU (1) HU226484B1 (fr)
ID (1) ID27275A (fr)
IL (1) IL128962A (fr)
IN (1) IN187156B (fr)
MY (1) MY125565A (fr)
NO (1) NO323980B1 (fr)
NZ (1) NZ334448A (fr)
PE (1) PE110398A1 (fr)
PL (3) PL194565B1 (fr)
PT (1) PT831098E (fr)
RS (1) RS49598B (fr)
SI (1) SI0831098T1 (fr)
SV (1) SV1997000081A (fr)
TR (1) TR199900640T2 (fr)
TW (1) TW470746B (fr)
UA (1) UA59371C2 (fr)
WO (1) WO1998012199A1 (fr)
ZA (1) ZA978515B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK2502003A3 (en) * 2000-08-31 2004-03-02 Reddys Lab Ltd Dr Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
EP1440074A1 (fr) * 2001-10-29 2004-07-28 Dr. Reddy's Laboratories Ltd. Dihydrate-ii d'olanzapine: son procede de preparation et son utilisation
AU2002367119A1 (en) 2001-12-24 2003-07-15 Sun Pharmaceutical Industries Limited Crystalline form I of 2-methyl-4-(4-methyl-1-piperazinyl) 10H thieno [2,3-b][1,5]benzodiazepine
AU2003243153A1 (en) * 2002-04-23 2003-11-10 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
US7297789B2 (en) 2002-05-31 2007-11-20 Sandoz, Inc. Process of preparation of olanzapine form I
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
US7323459B2 (en) * 2002-12-24 2008-01-29 Teva Pharmaceutical Industries Ltd. Crystal forms, methods for their preparation and method for preparation of olanzapine
US20070148218A1 (en) * 2003-11-18 2007-06-28 Gordon Ryan D Olanzapine containing transdermal drug delivery compositions
ATE397611T1 (de) * 2003-12-22 2008-06-15 Teva Pharma Verfahren zur herstellung von olanzapin
ATE504588T1 (de) 2004-01-27 2011-04-15 Synthon Bv Stabile salze von olanzapin
US20070072845A1 (en) * 2004-02-19 2007-03-29 Davuluri Rammohan Rao Process for the preparation of olanzapine form 1 useful as antipsychotic drug
DE05783995T1 (de) * 2004-07-14 2007-10-11 Shasun Chemicals and Drugs Ltd., Chennai Verbessertes verfahren zur herstellung von form i aus olanzapin
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
ES2303462B1 (es) * 2004-09-06 2009-06-05 Shasun Chemicals And Drugs Limited Nuevo procedimiento para la preparacion de una forma polimorfica i de olanzapina farmaceuticamente pura.
AU2005307797B2 (en) * 2004-11-16 2011-06-02 Alkermes Pharma Ireland Limited Injectable nanoparticulate olanzapine formulations
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (fr) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Nouvelles methodes de synthese de la forme-i de l'olanzapine
EP2486913A1 (fr) 2011-02-14 2012-08-15 Labtec GmbH Formulation de film oral à désintégration rapide pour olanzapine
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (fr) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates de beta-lactam antibiotiques
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
NZ247703A (en) * 1992-05-29 1995-07-26 Lilly Industries Ltd Thienobenzdiazepine derivatives and medicaments thereof
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
UA56184C2 (uk) * 1996-09-23 2003-05-15 Елі Ліллі Енд Компані Поліморфна модифікація оланзапіну дигідрату d, фармацевтична композиція та спосіб лікування психотичного стану

Also Published As

Publication number Publication date
EP0831098B1 (fr) 2001-11-21
UA59371C2 (uk) 2003-09-15
EP0831098A3 (fr) 1998-04-29
CZ99099A3 (cs) 1999-11-17
YU15599A (sh) 2001-12-26
DE69708428D1 (de) 2002-01-03
PL332482A1 (en) 1999-09-13
IN187156B (fr) 2002-02-16
NO991382L (no) 1999-03-22
EP0831098A2 (fr) 1998-03-25
NO991382D0 (no) 1999-03-22
HU226484B1 (en) 2009-03-02
HUP0000066A2 (hu) 2000-06-28
PE110398A1 (es) 1999-01-14
EG23861A (en) 2007-11-18
ZA978515B (en) 1999-03-23
AU719441B2 (en) 2000-05-11
KR20000048520A (ko) 2000-07-25
CA2265712C (fr) 2006-10-31
CN1122036C (zh) 2003-09-24
AU4484197A (en) 1998-04-14
IL128962A (en) 2003-01-12
HUP0000066A3 (en) 2000-11-28
AR013838A1 (es) 2001-01-31
SV1997000081A (es) 1999-01-14
PT831098E (pt) 2002-04-29
PL196069B1 (pl) 2007-12-31
JP2001500877A (ja) 2001-01-23
EA001642B1 (ru) 2001-06-25
RS49598B (sr) 2007-06-04
DK0831098T3 (da) 2002-05-21
CO4910140A1 (es) 2000-04-24
HK1009807A1 (en) 1999-06-11
CN1234802A (zh) 1999-11-10
CA2265712A1 (fr) 1998-03-26
JP2009242407A (ja) 2009-10-22
CZ299248B6 (cs) 2008-05-28
PL194565B1 (pl) 2007-06-29
ES2166051T3 (es) 2002-04-01
PL196068B1 (pl) 2007-12-31
TW470746B (en) 2002-01-01
MY125565A (en) 2006-08-30
KR100560015B1 (ko) 2006-03-15
US6020487A (en) 2000-02-01
IL128962A0 (en) 2000-02-17
BR9712100A (pt) 1999-08-31
NZ334448A (en) 2000-08-25
WO1998012199A1 (fr) 1998-03-26
EA199900326A1 (ru) 1999-08-26
TR199900640T2 (xx) 1999-06-21
NO323980B1 (no) 2007-07-30
SI0831098T1 (en) 2002-04-30
DE69708428T2 (de) 2002-07-04
ATE209208T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
ID19290A (id) Turunan-turunan propiofenon dan proses pembuatannya
ID16930A (id) Peralatan fotovoltaik dan proses untuk produksinya
ID18494A (id) Turunan pirazola leburan dan proses pembuatannya
ID28728A (id) Komposisi dan proses pengkrepan
ID15947A (id) Senyawa fenol dan proses pembuatannya
ID17271A (id) Proses untuk pengubahan etilbenzena
ID17307A (id) Komposisi oral dan proses pembuatannya.
ID23684A (id) Komposisi-polimer-organoclay dan pembuatannya
ID27275A (id) Intermediet dan proses untuk pembuatan olanzapin
ID30506A (id) Proses pengembangan ko-produksi 6-aminokapronitril dan heksametilenadiamino
ID15992A (id) Papan lamina dan proses pembuatannya
ID26902A (id) Proses dan radas untuk pembuatan melamina
ID18521A (id) Proses asetoksilasi olefin-olefin
ID16282A (id) Lensa intraokuler dan proses untuk pembuatannya
ID16923A (id) Komposisi-komposisi bitumen dan proses pembuatannya
ID18026A (id) Proses polimerisasi
ID16994A (id) Unit proses
ID19384A (id) Proses polimerisasi
ID15861A (id) Instalasi dan proses metalurgi mengandung fero
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
ID16410A (id) Proses produksi lipstatin dan tetrahidrolipstatin
ID26660A (id) Proses pembuatan butana-1,4-diol, gamma-butirolakton dan tetrahidrofuran
ID16617A (id) Proses penggilingan basah dan penggiling untuk melakukan proses tersebut
ID16858A (id) PROSES PEMBUATAN TERPOLIMER ETILENA SUATU-alpha-OLEFIN DAN DIENA.
ID15862A (id) Proses